|
⚲
|
| Keyboard |
| Lewis Geffen | |
|---|---|
| Firm | |
| Address | 42 Rockview Street, Unit 4 Boston, MA 02130 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Unravel Biosciences Inc | 021-409134 | Executive Officer | 0.5 M of 1.0 M |
||
| AURA Biosciences Inc | 021-337166 | Executive Officer | 20.0 M of 40.0 M |
||
| AURA Biosciences Inc | 021-302255 | Executive Officer | 42.3 M of 42.5 M |
||
| Opsonix Inc | 021-298365 | Executive Officer | 1.2 M of 1.2 M |
||
| Synlogic Inc | 021-287588 | Executive Officer | 42.0 M of 42.0 M |
||
| Tarsa Therapeutics Inc | 021-278462 | Executive Officer | 1.6 M of 1.6 M |
||
| AURA Biosciences Inc | 021-271656 | Executive Officer | 11.5 M of 11.5 M |
||
| Tarsa Therapeutics Inc | 021-266953 | Executive Officer | 1.2 M of 1.2 M |
||
| Synlogic LLC | 021-258214 | Executive Officer | 17.1 M of 17.1 M |
||
| Synlogic LLC | 021-258209 | Executive Officer | 13.9 M of 40.6 M |
||
| Tarsa Therapeutics Inc | 021-257818 | Executive Officer | 2.0 M of 2.0 M |
||
| Opsonix Inc | 021-248959 | Executive Officer | 4.0 M of 12.0 M |
||
| Lumen Labs Inc | 021-232899 | Executive Officer | 0.1 M of 1.0 M |
||
| Ambio Holdings Inc | 021-228681 | Executive Officer | 24.0 M of 24.0 M |
||
| Synlogic Inc | 021-221509 | Executive Officer | 4.0 M of 29.4 M |
||
| Decimmune Therapeutics Inc | 021-190385 | Executive Officer | 1.7 M of 2.2 M |
||
| Tarsa Therapeutics Inc | 021-175388 | Executive Officer | 13.8 M of 28.0 M |
||
| Decimmune Therapeutics Inc | 021-147924 | Executive Officer | 1.1 M of 1.1 M |
||